| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.027 | 0.9 |